Convidecia (redirect from Ad5-nCoV)
AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccine for COVID-19 that is also used as an inhaled booster. It was developed by CanSino...
36 KB (3,387 words) - 19:21, 12 September 2024
Adenoviridae (redirect from Ad5)
Recombinant adenovirus type-5 (Ad5) are being used by Ad5-nCoV, ImmunityBio and UQ-CSL V451. The Gam-COVID-Vac (aka Sputnik-V) product is innovative because...
49 KB (5,557 words) - 17:05, 5 August 2024
COVID-19 (redirect from 2019-nCoV Acute Respiratory Syndrome)
on 30 January 2021. Retrieved 21 December 2020. "The CanSino Biologics Ad5-nCoV-S [recombinant] COVID-19 vaccine: What you need to know". www.who.int....
288 KB (33,230 words) - 10:14, 12 September 2024
company has a portfolio of vaccines under research including Ad5-EBOV to prevent Ebola and Ad5-nCoV for COVID-19. The company has previously collaborated with...
15 KB (1,099 words) - 19:03, 12 September 2024
COVID-19 vaccine (redirect from SARS-CoV-2 vaccine)
on 30 January 2021. Retrieved 21 December 2020. "The CanSino Biologics Ad5-nCoV-S [recombinant] COVID-19 vaccine: What you need to know". www.who.int....
200 KB (22,796 words) - 05:34, 12 September 2024
V by the Gamaleya Institute (February 2, 2021) Ad5-nCoV by CanSino Biologics Inc. (February 9, 2021) CoronaVac by Sinovac Research and Development Co...
10 KB (796 words) - 15:33, 1 January 2024
tozinameran and mRNA-1273, the DNA vaccine ZyCoV-D as well as the viral vectors AZD1222, Ad26.COV2.S, Ad5-nCoV, and Sputnik V. In addition, genetic vaccines are...
8 KB (1,186 words) - 05:09, 11 June 2024
COVID-19 vaccine Ad5-Ncov: Ifax". Reuters. 2020-12-07. Archived from the original on December 7, 2020. Retrieved 2020-12-07. Eltahir N (9 August 2020)...
12 KB (1,008 words) - 18:05, 12 September 2024
Biologics to conduct clinical trials for its COVID-19 vaccine candidate Ad5-nCoV at Dalhousie University in Nova Scotia. The NRC cited its "strong collaborative...
185 KB (14,787 words) - 04:28, 26 July 2024